Banner - NPPA Connect

Opinion|Videos|September 5, 2024

Composite Scores and Quality of Life: A New Standard for AD Management

Author(s)Christopher G. Bunick, MD, PhD, Raj Chovatiya, MD, PhD, MSCI

Atopic dermatitis experts evaluate the integration of composite scores and quality of life measures as a new benchmark for comprehensive disease management.

Episodes in this series

2 KOLs are featured in this series.

EP. 1 Evaluating Treatment Efficacy: Identifying and Managing AD Flares in Systemic Therapy Patients

2 KOLs are featured in this series.

EP. 2 Composite Scores and Quality of Life: A New Standard for AD Management

2 KOLs are featured in this series.

EP. 3 From Trial to Practice: Applying Study Results to Real-World AD Management

2 KOLs are featured in this series.

EP. 4 Comprehensive Analysis: Upa Outshines Dupi Across Key Measures

2 KOLs are featured in this series.

EP. 5 From Clinic to Practice: Translating AD Trial Data

2 KOLs are featured in this series.

EP. 6 Final Thoughts: The Importance of Comparative Studies in AD

2 KOLs are featured in this series.

EP. 7 Improved Quality of Life: Upadacitinib's Role in Managing AD

EP. 8 Experts Delve Into Upadacitinib vs Dupilumab: Insights From LEVEL UP

EP. 8 Experts Delve Into Upadacitinib vs Dupilumab: Insights From LEVEL UP

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

1 expert is featured in this series

Why Patient-Reported Outcomes Matter in Psoriasis Care

ByTina Bhutani-Jacques, MD

September 11th 2026

1 expert is featured in this series

Addressing Steroid Fear with Non-Steroidal Treatment Options in Psoriasis

ByTina Bhutani-Jacques, MD

September 4th 2026

1 expert is featured in this series

Setting Realistic Treatment Goals for Localized Plaque Psoriasis

ByTina Bhutani-Jacques, MD

September 4th 2026

1 expert is featured in this series

Skin Clearance and PsA Prevention with Biologics in Psoriasis

ByBruce Strober, MD, PhD

September 1st 2026

1 expert is featured in this series

Case 3: Redefining How We Classify Psoriasis Severity

ByTina Bhutani-Jacques, MD

August 28th 2026

Trending on Dermatology Times

How Emerging Androgenetic Alopecia Therapies Target DHT at the Scalp Level

Tildrakizumab Partially Reverses Epigenetic Aging in Psoriasis, Pilot Study Shows

Field-Directed Therapy Favored for Actinic Keratosis Management

Diet Linked to Improved Chronic Idiopathic Urticaria Control

From Biopsy to Biomarkers: Experts Navigate Skin Cancer Diagnosis and Staging